Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease
Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease have?
Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease has 38 citations in the OpenAlex counts ScholarIQ stores.
When was Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease published?
Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease has 2020 year in the ScholarIQ index.
What is the open-access status of Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease?
Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease has gold oa status in the ScholarIQ index.
What is the DOI of Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease?
The DOI for Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease is on the source record.
What is the PMID of Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease?
The PMID for Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease is on the source record.
What is the OpenAlex record for Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease?
The OpenAlex for Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease is on the source record.